Mr. Speaker, recent news reports reveal that the tax evasion office of Revenue Quebec is preparing to launch an investigation into an alleged discount scheme involving generic drug companies and the province's pharmacists. Those same reports reveal that such practices, which may well be keeping drug prices unnecessarily high, might be going on across Canada.
Will the Minister of National Revenue tell the House whether her department is aware of the issue and is she contemplating following Quebec's lead and launching her own investigation?